Literature DB >> 8689390

Lack of a role for bradykinin in allergen-induced airway microvascular leakage and bronchoconstriction in the guinea pig.

T Sakamoto1, P J Barnes, K F Chung.   

Abstract

We have investigated the role of bradykinin in allergen-induced airway microvascular leakage and bronchoconstriction in sensitized guinea pigs. We used a selective bradykinin B2 receptor antagonist, HOE140, which has been shown to prevent the airway effects induced by bradykinin. Lung resistance (RL) was measured for 6 min after challenge with allergen. Extravasation of Evans blue dye into airway tissues was used as an index of the airway microvascular leakage. Aerosolized ovalbumin (5 mg/ml, 30 breaths) induced a significant increase in RL and leakage of dye in the trachea, main bronchi and intrapulmonary airways in the ovalbumin-sensitized guinea pigs. HOE140 given by inhalation (200 microM, 60 breaths) had no effect on the airway microvascular leakage and bronchoconstriction induced by the allergen. I.v. HOE140 (200 nmol/kg) did not significantly inhibit these airway responses. We conclude that bradykinin-mediated mechanism may not play a significant role in airway microvascular leakage or bronchoconstriction induced by allergen.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8689390     DOI: 10.1007/bf02265164

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  23 in total

1.  The bronchoconstrictor action of bradykinin in the guinea-pig.

Authors:  H O COLLIER; J A HOLGATE; M SCHACHTER; P G SHORLEY
Journal:  Br J Pharmacol Chemother       Date:  1960-06

2.  Bradykinin-induced plasma exudation in guinea-pig airways: involvement of platelet activating factor.

Authors:  D F Rogers; S Dijk; P J Barnes
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

3.  Capsaicin pretreatment does not inhibit allergen-induced airway microvascular leakage in guinea pig.

Authors:  J O Lötvall; K P Hui; C G Löfdahl; P J Barnes; K F Chung
Journal:  Allergy       Date:  1991-02       Impact factor: 13.146

Review 4.  Inflammatory mediators and asthma.

Authors:  P J Barnes; K F Chung; C P Page
Journal:  Pharmacol Rev       Date:  1988-03       Impact factor: 25.468

5.  Role of kinins in the vascular extravasation evoked by antigen and mediated by tachykinins in guinea pig trachea.

Authors:  C Bertrand; J A Nadel; I Yamawaki; P Geppetti
Journal:  J Immunol       Date:  1993-11-01       Impact factor: 5.422

6.  Effect of Hoe 140 on bradykinin-induced bronchoconstriction in anesthetized guinea pigs.

Authors:  K J Wirth; D Gehring; B A Schölkens
Journal:  Am Rev Respir Dis       Date:  1993-09

7.  Bradykinin-induced bronchoconstriction in humans. Mode of action.

Authors:  R W Fuller; C M Dixon; F M Cuss; P J Barnes
Journal:  Am Rev Respir Dis       Date:  1987-01

8.  Vascular protein linkage in various tissue induced by substance P, capsaicin, bradykinin, serotonin, histamine and by antigen challenge.

Authors:  A Saria; J M Lundberg; G Skofitsch; F Lembeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-11       Impact factor: 3.000

9.  Role of kinins in anaphylactic-induced bronchoconstriction mediated by tachykinins in guinea-pigs.

Authors:  F L Ricciardolo; J A Nadel; P D Graf; C Bertrand; S Yoshihara; P Geppetti
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

10.  Effect of Hoe 140, a new bradykinin receptor antagonist, on bradykinin- and platelet-activating factor-induced bronchoconstriction and airway microvascular leakage in guinea pig.

Authors:  T Sakamoto; W Elwood; P J Barnes; K F Chung
Journal:  Eur J Pharmacol       Date:  1992-03-31       Impact factor: 4.432

View more
  1 in total

1.  Suppressive effect of distinct bradykinin B2 receptor antagonist on allergen-evoked exudation and leukocyte infiltration in sensitized rats.

Authors:  C Bandeira-Melo; A S Calheiros; P M Silva; R S Cordeiro; M M Teixeira; M A Martins
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.